☆ 4.1 Editorial Material

Invasive fungal diseases during COVID-19: We should be prepared

JOURNAL DE MYCOLOGIE MEDICALE (2020)

期刊

JOURNAL DE MYCOLOGIE MEDICALE

卷 30, 期 2, 页码 -

出版社

MASSON EDITEUR

DOI: 10.1016/j.mycmed.2020.100971

关键词

Covid fungal; Covid aspergillosis; Covid Aspergillus; Covid Pneumocystis; Covid pneumocystosis; Covid mucorales

类别

Mycology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Dermatology

Role of flexible bronchoscopy in the diagnosis of invasive fungal infections

Valliappan Muthu, Raghava Rao Gandra, Sahajal Dhooria, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Harsimran Kaur, Nalini Gupta, Amanjit Bal, Babu Ram, Ashutosh N. Aggarwal, Arunaloke Chakrabarti, Ritesh Agarwal

Summary: Flexible bronchoscopy is a safe and effective method for diagnosing invasive mould infections, with a higher success rate of diagnosis in patients with endobronchial abnormalities.

MYCOSES (2021)

添加到收藏夹

Article Microbiology

Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves

Letizia Cattaneo, Antonio Riccardo Buonomo, Carmine Iacovazzo, Agnese Giaccone, Riccardo Scotto, Giulio Viceconte, Simona Mercinelli, Maria Vargas, Emanuela Roscetto, Francesco Cacciatore, Paola Salvatore, Maria Rosaria Catania, Riccardo Villari, Antonio Cittadini, Ivan Gentile

Summary: Invasive fungal infections (IFIs) are severe and under-estimated complications of COVID-19. A retrospective analysis of COVID-19 patients admitted to a hospital in Naples found cases of IFIs caused by Candida spp., Pneumocystis jirovecii pneumonia, invasive pulmonary aspergillosis, and Trichosporon asahii. Most cases were not associated with underlying predisposing conditions and were linked to high-dose steroid therapy and lymphopenia with CD4+ < 200/μL due to SARS-CoV-2 infection. IFIs significantly increased hospitalization duration and mortality in COVID-19 patients.

JOURNAL OF FUNGI (2023)

添加到收藏夹

Article Microbiology

COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave

Stephane Bretagne, Karine Sitbon, Francoise Botterel, Sarah Delliere, Valerie Letscher-Bru, Taieb Chouaki, Anne-Pauline Bellanger, Christine Bonnal, Arnault Fekkar, Florence Persat, Damien Costa, Nathalie Bourgeois, Frederic Dalle, Florian Lussac-Sorton, Andre Paugam, Sophie Cassaing, Lilia Hasseine, Antoine Huguenin, Nadia Guennouni, Edith Mazars, Solene Le Gal, Milene Sasso, Sophie Brun, Lucile Cadot, Carole Cassagne, Estelle Cateau, Jean-Pierre Gangneux, Maxime Moniot, Anne-Laure Roux, Celine Tournus, Nicole Desbois-Nogard, Alain Le Coustumier, Olivier Moquet, Alexandre Alanio, Francoise Dromer

Summary: To diagnose fungal coinfections in patients with COVID-19 in the ICU, it is important to implement correct treatment and prevention. Respiratory specimens remain the best approach for diagnosing CAPA, while fungemias are associated with a mortality rate of 45.7% in ICU patients. Pneumocystosis mainly occurs in immunocompromised patients and is diagnosed at ICU admission.

MICROBIOLOGY SPECTRUM (2021)

添加到收藏夹

Review Multidisciplinary Sciences

Pneumocystis pneumonia in COVID-19 patients: A comprehensive review

Elahe Sasani, Fares Bahrami, Mohammadreza Salehi, Farzad Aala, Ronak Bakhtiari, Alireza Abdollahi, Bahareh Bashardoust, Mahsa Abdorahimi, Sadegh Khodavaisy

Summary: The admitted patients of intensive care units with COVID-19 face the challenges of subsequent infections, including opportunistic fungal infections such as PCP, which can affect illness severity and mortality. PCP can occur in both immunosuppressed and immunocompetent patients who develop immunosuppression during COVID-19 treatment. Low lymphocyte counts and corticosteroid therapy are major risk factors associated with COVID-19 patients with PCP. Diagnosing and treating PCP in COVID-19 patients can be complicated due to overlapping clinical and radiologic characteristics, thus physicians should evaluate high-risk patients comprehensively for PCP prophylaxis.

HELIYON (2023)

添加到收藏夹

Article Critical Care Medicine

Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU

Arnaud Fekkar, Alexandre Lampros, Julien Mayaux, Corentin Poignon, Sophie Demeret, Jean-Michel Constantin, Anne-Genevieve Marcelin, Antoine Monsel, Charles-Edouard Luyt, Marion Blaize

Summary: This study examined the occurrence of invasive fungal respiratory superinfections in severe COVID-19 patients admitted to five ICUs in France, finding that patients with no underlying immunosuppression seem at low risk of invasive fungal secondary infection.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents

Mahzad Erami, Shima Aboutalebian, Seyed Jamal Hashemi Hezaveh, Roshanak Daie Ghazvini, Mansooreh Momen-Heravi, Yazdan Jafari, Amir Hossein Ahsaniarani, Bahare Basirpour, Amir Hassan Matini, Hossein Mirhendi

Summary: This study identified various types of fungi in COVID-19 patients with invasive fungal rhinosinusitis (IFRS), highlighting the need for specific treatments. Since the global spread of COVID-19, IFRS has emerged as a new clinical challenge for immunocompromised patients.

MEDICAL MYCOLOGY (2023)

添加到收藏夹

Article Microbiology

Detection of Pneumocystis jirovecii in Patients with Severe COVID-19: Diagnostic and Therapeutic Challenges

Victor Gerber, Yvon Ruch, Thien-Nga Chamaraux-Tran, Walid Oulehri, Francis Schneider, Veronique Lindner, Valentin Greigert, Julie Denis, Julie Brunet, Francois Danion

Summary: This study found that cases of Pneumocystis jirovecii pneumonia occasionally occur in patients with COVID-19, particularly in elderly individuals with immunodeficiency or diabetes. These co-infections typically have a poor prognosis, leading to severe pneumonia progression and ultimately death.

JOURNAL OF FUNGI (2021)

添加到收藏夹

Review Microbiology

Invasive Fungal Diseases in Africa: A Critical Literature Review

Felix Bongomin, Bassey. E. E. Ekeng, Winnie Kibone, Lauryn Nsenga, Ronald Olum, Asa Itam-Eyo, Marius Paulin Ngouanom Kuate, Francis Pebalo Pebolo, Adeyinka. A. A. Davies, Musa Manga, Bright Ocansey, Richard Kwizera, Joseph Baruch Baluku

Summary: Invasive fungal diseases (IFDs) pose a significant challenge in resource-limited settings in Africa, where diagnostic tools and antifungal therapies are lacking. Cryptococcosis is the most common IFD in Africa, followed by invasive aspergillosis and histoplasmosis. Investment in fungal-related research and antifungal therapy is crucial to address the burden of IFDs in Africa.

JOURNAL OF FUNGI (2022)

添加到收藏夹

Article Microbiology

A Clustered Case Series of Mucorales Detection in Respiratory Samples from COVID-19 Patients in Intensive Care, France, August to September 2021

Emilie Guemas, Sophie Cassaing, Sandra Malavaud, Judith Fillaux, Pamela Chauvin, Lucie Lelievre, Stephanie Ruiz, Beatrice Riu, Antoine Berry, Xavier Iriart

Summary: This retrospective study investigated fungal infections among COVID-19 adult patients in an ICU in Southern France. The study found that COVID-19-associated aspergillosis was common, while mucormycosis seemed to be rare. However, in industrialized countries, a cluster of cases can still occur if environmental conditions in ICU, particularly during construction work, are associated with a high number of COVID-19 patients.

JOURNAL OF FUNGI (2022)

添加到收藏夹

Review Microbiology

Invasive Fungal Infections Associated with COVID-19

Kyaw M. Hlaing, Lea M. Monday, Marcio Nucci, Simone A. Nouer, Sanjay G. Revankar

Summary: The COVID-19 pandemic has caused over 6 million deaths worldwide, largely due to respiratory failure. Hospitalized patients, especially those in the intensive care unit, frequently experience complications. Fungal infections, including invasive aspergillosis, candidiasis, and mucormycosis, have posed significant morbidity and mortality risks. Risk factors include changes in immune defenses caused by COVID-19 and immunosuppression from various therapies in severely ill patients. Diagnosis is often challenging due to limited sensitivity of current tests. Overall outcomes are poor, with mortality rates exceeding 50% in some studies, primarily due to comorbidities and delayed diagnosis. Early diagnosis and appropriate antifungal therapy require a high index of clinical suspicion.

JOURNAL OF FUNGI (2023)

添加到收藏夹

Review Microbiology

Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients

Francesca Raffaelli, Eloisa Sofia Tanzarella, Gennaro De Pascale, Mario Tumbarello

Summary: Patients with COVID-19 in the ICU often develop respiratory fungal infections, including CAPA, CAPM, and PCP. Multiple risk factors promote these infections, such as epithelial damage, mechanical ventilation, and immunosuppression. Differentiating between colonization and infection in COVID-19 patients is challenging, and reliable diagnostic approaches are limited. Although several antifungal drugs are available, the development of more effective and less toxic drugs is needed.

JOURNAL OF FUNGI (2022)

添加到收藏夹

Article Dermatology

Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study

Valliappan Muthu, Mohan Kumar, Raees A. Paul, Deepy Zohmangaihi, Hansraj Choudhary, Shivaprakash M. Rudramurthy, Naresh K. Panda, Ashok Kumar Pannu, Navneet Sharma, Sadhna Sharma, Arunaloke Chakrabarti, Ritesh Agarwal

Summary: An increase in growth was observed in Rhizopus arrhizus isolates in zinc-enriched media, but the study did not conclusively support the hypothesis that zinc supplementation contributed to the pathogenesis of mucormycosis. More data, both in vitro and in vivo, may help clarify the role of zinc in the pathogenesis of CAM.

MYCOSES (2021)

添加到收藏夹

Review Microbiology

Epidemiology of Systemic Mycoses in the COVID-19 Pandemic

Maria Guadalupe Frias-De-Leon, Rodolfo Pinto-Almazan, Rigoberto Hernandez-Castro, Eduardo Garcia-Salazar, Patricia Meza-Meneses, Carmen Rodriguez-Cerdeira, Roberto Arenas, Esther Conde-Cuevas, Gustavo Acosta-Altamirano, Erick Martinez-Herrera

Summary: Co-infections of COVID-19 with various fungal diseases mainly occur in males over the age of 40 with immunosuppression as the primary risk factor. Challenges exist in diagnosis and treatment, and there is a need to increase awareness of fungal infections.

JOURNAL OF FUNGI (2021)

添加到收藏夹

Article Infectious Diseases

Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response

Dionysios Neofytos, Carolina Garcia-Vidal, Frederic Lamoth, Christoph Lichtenstern, Alessandro Perrella, Joerg Janne Vehreschild

Summary: The diagnosis and management of invasive aspergillosis in solid organ transplant recipients pose challenges and require specialized attention. Further research is needed to evaluate treatment response criteria and develop comprehensive guidelines for this population.

BMC INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Allergy

Poorly controlled asthma- Easy wins and future prospects for addressing fungal allergy

David W. Denning, Lorraine T. Pfavayi

Summary: Poorly controlled asthma is common in low resource countries. Fungal allergy and exposure are often associated with severe asthma, and antifungal therapy can improve symptoms and reduce exacerbations.

ALLERGOLOGY INTERNATIONAL (2023)

添加到收藏夹

Article Microbiology

In Vitro Antifungal Combination of Terbinafine with Itraconazole against Isolates of Trichophyton Species

Anne-Laure Bidaud, Patrick Schwarz, Anuradha Chowdhary, Eric Dannaoui

Summary: A combination of terbinafine with itraconazole was found to have synergistic effects against both terbinafine-susceptible and terbinafine-resistant isolates of Trichophyton spp. from India.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Review Infectious Diseases

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

Martin Hoenigl, Danila Seidel, Agostinho Carvalho, Shivaprakash M. Rudramurthy, Amir Arastehfar, Jean-Pierre Gangneux, Nosheen Nasir, Alexandro Bonifaz, Javier Araiza, Nikolai Klimko, Alexandra Serris, Katrien Lagrou, Jacques F. Meis, Oliver A. Cornely, John R. Perfect, P. Lewis White, Arunaloke Chakrabarti

Summary: Reports of COVID-19-associated mucormycosis, particularly among patients with uncontrolled diabetes, have been increasing since early 2021. Most patients with COVID-19-associated mucormycosis have uncontrolled diabetes and receive systemic corticosteroid treatment, and rhino-orbital cerebral mucormycosis is the most common disease. COVID-19-associated mucormycosis is associated with high mortality and a significant proportion of survivors experience life-changing morbidities.

LANCET MICROBE (2022)

添加到收藏夹

Review Mycology

Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species

Hamed Fakhim, Hamid Badali, Eric Dannaoui, Maryam Nasirian, Fateme Jahangiri, Maedeh Raei, Narges Vaseghi, Kazem Ahmadikia, Afsane Vaezi

Summary: This study provides a global perspective on the prevalence, geographic distribution, and trend of amphotericin B resistance (AmBR) in Aspergillus species. The common AmB-resistant species differ between Asian, European, and American studies. Future research should focus on regional trends and standardized methodologies.

JOURNAL DE MYCOLOGIE MEDICALE (2022)

添加到收藏夹

Meeting Abstract Infectious Diseases

Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.

Anne-Laure Bidaud, Alicia Moreno-Sabater, Anne-Cecile Normand, Genevieve Cremer, Francoise Foulet, Sophie Brun, Aymen Ayachi, Sebastien Imbert, Anuradha Chowdhary, Eric Dannaoui

MEDICAL MYCOLOGY (2022)

添加到收藏夹

Article Infectious Diseases

Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes

Victor Mercier, Valerie Letscher-Bru, Marie-Elisabeth Bougnoux, Laurence Delhaes, Francoise Botterel, Daniele Maubon, Frederic Dalle, Alexandre Alanio, Sandrine Houze, Eric Dannaoui, Carole Cassagne, Sophie Cassaing, Marie-Fleur Durieux, Arnaud Fekkar, Jean-Philippe Bouchara, Jean-Pierre Gangneux, Julie Bonhomme, Damien Dupont, Damien Costa, Boualem Sendid, Taieb Chouaki, Nathalie Bourgeois, Antoine Huguenin, Sophie Brun, Caroline Mahinc, Lilia Hasseine, Solene Le Gal, Anne-Pauline Bellanger, Eric Bailly, Florent Morio, Celine Nourrisson, Nicole Desbois-Nogard, Estelle Perraud-Cateau, Anne Debourgogne, Helene Yera, Laurence Lachaud, Milene Sasso

Summary: The study aimed to determine the epidemiological cut-off values (ECVs) of ten antifungal agents in a wide range of yeasts and Aspergillus spp. using gradient concentration strips. Retrospective collection of minimum inhibitory concentrations for various antifungal agents was done from 35 French microbiology laboratories between 2002 and 2020. The calculated ECVs can aid in interpreting minimum inhibitory concentrations and identifying non-wild type isolates.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

添加到收藏夹

Article Environmental Sciences

Environmental and bioclimatic factors influencing yeasts and molds distribution along European shores

M. Cogliati, S. Arikan-Akdagli, A. Barac, A. C. Bostanaru, S. Brito, N. Cerikcioglu, M. A. Efstratiou, C. Ergin, M. C. Esposto, M. Frenkel, J. P. Gungneux, A. Gitto, C. I. Goncalves, H. Guegan, N. Gunde-Cimerman, M. Guran, E. Jonikaite, M. Katarzyte, L. Klingspor, M. Mares, W. G. Meijer, W. J. G. Melchers, J. Meletiadis, V. Nastasa, M. Novak Babic, D. Ogunc, B. Ozhak, A. Prigitano, S. Ranque, L. Romano, R. O. Rusu, R. Sabino, A. Sampaio, S. Silva, J. H. Stephens, M. Tehupeiory-Kooreman, A. Velegraki, C. Verissimo, E. Segal, J. Brandao

Summary: The study used data from the Mycosands survey to investigate the factors affecting the distribution of yeasts and molds along European shores. Environmental factors such as climate, soil properties, and water conditions were analyzed using species distribution modelling. The results showed that yeasts and molds have different distributions along European shores, with yeasts being more tolerant of low temperatures and molds showing affinity with specific soil compositions and water conditions.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

添加到收藏夹

Article Immunology

In vitro and in vivo evaluation of antifungal combinations against azole-resistant Aspergillus fumigatus isolates

Sana Jemel, Yannick Raveloarisaona, Anne-Laure Bidaud, Elie Djenontin, Aicha Kallel, Jacques Guillot, Kalthoum Kallel, Francoise Botterel, Eric Dannaoui

Summary: Azole resistance in Aspergillus fumigatus is a major concern for the optimal management of patients with invasive aspergillosis. This study evaluates the combination of caspofungin with voriconazole or posaconazole for the treatment of azole-resistant strains. In vitro and in vivo experiments were conducted, and the combination therapy showed promising results.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

添加到收藏夹

Article Microbiology

Evaluation of Gradient Concentration Strips for Detection of Terbinafine Resistance in Trichophyton spp.

Anne-Laure Bidaud, Alicia Moreno-Sabater, Anne-Cecile Normand, Genevieve Cremer, Francoise Foulet, Sophie Brun, Aymen Ayachi, Sebastien Imbert, Anuradha Chowdhary, Eric Dannaoui

Summary: The number of dermatophytosis cases resistant to terbinafine is increasing globally, highlighting the importance of antifungal susceptibility testing for better patient management. A gradient test (GT) method was evaluated for testing the susceptibility of dermatophytes to terbinafine. The MIC values determined by the GT method were lower than the EUCAST reference technique, indicating its potential as a reliable alternative.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

添加到收藏夹

Article Infectious Diseases

Reliability of a terbinafine agar containing method for the screening of dermatophyte resistance

Anne-Laure Bidaud, Anne-Cecile Normand, Arnaud Jabet, Sophie Brun, Sarah Delliere, Genevieve Cremer, Francoise Foulet, Aymen Ayachi, Sebastien Imbert, Christophe Hennequin, Eric Dannaoui, Alicia Moreno-Sabater

Summary: The increase in terbinafine resistance worldwide due to Trichophyton indotineae necessitates surveillance networks. The terbinafine containing agar method is a reliable and easy-to-use tool in clinical microbiology laboratories, allowing for rapid screening of resistant isolates and reducing their spread.

MEDICAL MYCOLOGY (2023)

添加到收藏夹

Review Mycology

Trichophyton indotineae, from epidemiology to therapeutic

Arnaud Jabet, Anne-Cecile Normand, Sophie Brun, Eric Dannaoui, Claude Bachmeyer, Renaud Piarroux, Christophe Hennequin, Alicia Moreno-Sabater

Summary: Trichophyton indotineae is a newly described dermatophyte species that has emerged in India and causes chronic or recurrent widespread superficial infections. Resistance to terbinafine is common in this pathogen and is associated with point mutations in the squalene epoxidase gene. T. indotineae infections have been reported outside India, indicating the potential global spread of this microorganism. Accurate species identification and determination of antifungal susceptibility remain challenging but crucial for infection control. Systemic treatment with itraconazole is usually necessary in cases of terbinafine resistance. This review provides a comprehensive summary of T. indotineae taxonomy, epidemiology, clinical manifestations, identification, antifungal profile, treatment, and prevention.

JOURNAL DE MYCOLOGIE MEDICALE (2023)

添加到收藏夹

Article Medical Laboratory Technology

Comparison of the New VITEK MS PRIME System with the Matrix-Assisted Laser Desorption Ionization Biotyper Microflex LT for the Identification of Microorganisms

Patrick Grohs, Elodie Remaud, Cybill Lath, Kim Vuong, Marie-Lize Parolini, Eric Dannaoui, Isabelle Podglajen

Summary: This study compared the performance of the MBT system and the VMS-P system in bacterial identification. The results showed that the two systems performed similarly in routine practice, but the VMS-P system demonstrated better repeatability, confidence scores for identification, and ability to identify microcolonies.

ANNALS OF LABORATORY MEDICINE (2023)

添加到收藏夹

Article Microbiology

The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals

Elie Djenontin, Jean-Marc Costa, Bita Mousavi, Lin Do Ngoc Nguyen, Jacques Guillot, Laurence Delhaes, Francoise Botterel, Eric Dannaoui

Summary: This study identified a large collection of Aspergillus in the Flavi section, confirming that A. flavus ss is the predominant species. It is mainly associated with respiratory and ENT infections. The emergence of resistance highlights the need for susceptibility testing on Flavi section isolates.

MICROORGANISMS (2023)

添加到收藏夹

Article Microbiology

Comparison of the Micronaut-AM System and the EUCAST Broth Microdilution Reference Method for MIC Determination of Four Antifungals against Aspergillus fumigatus

Nikolett Gyurtane Szabo, Valentin Joste, Sandrine Houze, Eric Dannaoui, Christine Bonnal

Summary: This study evaluated the performance of the Micronaut-AM (M-AM) system for determining the susceptibility of A. fumigatus strains to antifungal drugs and compared it with the EUCAST broth microdilution reference method. The M-AM system showed good performance for determining the Minimum Inhibitory Concentration (MIC) of amphotericin B, but further evaluations are needed for the MIC determination of azoles.

JOURNAL OF FUNGI (2023)

添加到收藏夹

Review Infectious Diseases

The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey

Jon Salmanton-Garcia, Martin Hoenigl, Jean-Pierre Gangneux, Esther Segal, Ana Alastruey-Izquierdo, Sevtap Arikan Akdagli, Katrien Lagrou, Volkan oezenci, Antonio Vena, Oliver A. Cornely

Summary: The diagnostic capacity for invasive fungal infections in Europe is generally good, but there are limitations in access to certain diagnostic tools and antifungal drugs. These limitations need to be addressed to ensure optimal diagnosis and treatment for all patients.

LANCET MICROBE (2023)

添加到收藏夹

Article Immunology

Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, France

Arnaud Jabet, Sophie Brun, Anne-Cecile Normand, Sebastien Imbert, Mohammad Akhoundi, Eric Dannaoui, Laeticia Audiffred, Francois Chasset, Arezki Izri, Liliane Laroche, Renaud Piarroux, Claude Bachmeyer, Christophe Hennequin, Alicia Moreno Sabater

Summary: Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae was diagnosed in France. Analysis of sequences suggests that this species is widely distributed in Asia and Europe, and animals may serve as reservoirs.

EMERGING INFECTIOUS DISEASES (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.